Future healthcare will include diagnosis and treatment of genetic diseases. This will become possible by understanding genetic information gleaned from efforts such as the Human Genome Project and others. Tools need to be developed to use that information in diagnostic and therapeutic products for clinical laboratories, physicians' offices and eventually the home.

This talk will discuss the present and emerging markets for microarrays, and the technologies used in Motorola Life Sciences products to address these markets (DNA, RNA and proteins). Emerging technologies such as microfluidics will also be discussed followed by possibilities of what nucleic acid diagnostics might become in the future.

Presentation slides:

• Link to Presentation